NL-OMON37765已完成2 期
Δ9-THC (Namisol®) in chronic pancreatitis patients suffering from persistent abdominal pain: a randomized, double-blinded, placebo-controlled, parallel design - Δ9-THC in chronic pancreatitis
niversitair Medisch Centrum Sint Radboud0 个研究点目标入组 68 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 68
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Aged 18 years or older
- •Confirmed chronic pancreatitis
- •Pain duration exceeding 3 months, and average NRS>=3
- •Stable doses intake of analgesics for the past 2 months
- •Patient has been informed about the study, understood the information and signed the informed consent form
排除标准
- •Patient took cannabinoids on a regular basis for at least one year
- •Patient does not feel a pinprick test in the lower extremities
- •Patient has a body mass index (BMI) above 33,0 kg/m2
- •Patient has a significant medical disorder that may interfere with the study or may pose a risk for the patient
- •Patient uses any kind of concomitant medication that may interfere with the study or may pose a risk for the patient
- •Patient takes amitriptyline on a daily basis
- •Patient does not tolerate oral intake of medication or liquids, or is refrained from oral intake because of medical reasons
- •Patient demonstrates clinical relevant deviations in the electrocardiogram (ECG)
- •Patient has an actual moderate to severe renal impairment
- •Patient has an actual moderate to severe hepatic impairment
- •Patient has a presence or history of major psychiatric illness
- •Patient has experienced an epileptic seizure in the past
- •Patient demonstrates clinically significant laboratory abnormalities
- •Patient demonstrates a positive urine drug screen for THC, cocaine, MDMA, and amphetamines
- •Patient demonstrates a positive test result on hepatitis B surface antigen, hepatitis C antibody or HIV antibody test
- •Patient has a history of sensitivity / idiosyncrasy to THC
- •Patient has a known or suspected lactose intolerance
- •Female patient is pregnant or breastfeeding
- •Patient intends to conceive a child during the course of the study
- •Patient participates in another investigational drug study
- •Patient has a clinical significant exacerbation in illness
- •Patient is unwilling or unable to comply with the lifestyle guidelines
研究者
相似试验
已完成
2 期
Δ9-THC (Namisol®) in Chronic Pancreatitis Patients Suffering From Persistent Abdominal PainPancreatitis, ChronicAbdominal PainChronic PainNCT01551511Radboud University Medical Center29
招募中
1 期
Tocilizumab for Painful Chronic Pancreatitis (TOPAC-trial)Chronic pancreatitisMedDRA version: 20.1Level: LLTClassification code: 10009093Term: Chronic pancreatitis Class: 10017947CTIS2023-510084-35-00Aalborg University Hospital36
已完成
不适用
Pancreatitis of biliary origin: Optimal timiNg CHOlecystectomy (PONCHO) trialAcute pancreatitisISRCTN72764151Radboud University Nijmegen Medical Centre (Netherlands)265
已完成
不适用
Surgical Outcome for Internal Pancreatic FistulaChronic Pancreatitis Related Pancreatic Ascites and Pancreatic Pleural Effusionpancreatic ascitessurgeryoutcomepleural effusionchronic pancreatitisTCTR20220101004Institute of Postgraduate Medical Education and Research, Kolkata, India10
尚未招募
不适用
Acute alvleesklierontsteking van onbekende oorzaak: de rol van een inwendige echo in het vaststellen van een oorzaakPancreatitisAcute pancreatitisIdiopathic pancreatitisIdiopathische pancreatitisIdiopathic acute pancreatitis Idiopathische acute pancreatitis Endoscopic ultrasonographyEndoscopic ultrasoundEndo-echoEndoscopische echografieEndoscopische echo AetiologyEtiologyEtiologieNL-OMON25133Prof. Dr. P. Fockens, MD, PhD Head of department Department of Gastroenterology & HepatologyC2-330 Academic Medical Center Meibergdreef 9 1105 AZ, Amsterdam106